Close enough to be mistaken.
- Mechanism
- Cross-reactive immune response
- Evidence
- Documented cases, with primary sources
- Types
- Sequence · structure · carbohydrate
Molecular mimicry is the resemblance between a pathogen molecule and a human one, close enough for the response raised against the first to recognise the second as well. It is documented in human disease, and accounts for part of autoimmunity.
When a microbe looks like us, the immune system can mistake us for the microbe.
Many causes. One lead.
Autoimmunity appears when a predisposition meets a trigger. Of all the factors described, we follow one: infection, and the mechanism through which it has been best shown to act.
- Genetics
- Sex and hormones
- Infections
- Drugs
- Environment
- Microbiota
Our betMolecular mimicry
Autoimmunity
Most infections pass in silence.
We are exposed to far more pathogens than we ever record. When a fragment of one matches a fragment of our own, the response it provokes can stay pointed at the host's tissue long after the infection has cleared.1
- 01
Exposure
An infection, often subclinical, activates B and T cells against the pathogen's antigens.
- 02
Resemblance
A pathogen epitope matches one of our own: a stretch of sequence, an equivalent fold or an identical carbohydrate structure.
- 03
Presentation
That shared epitope is presented in the context of particular HLA molecules and meets a self-reactive lymphocyte that escaped tolerance.
- 04
Cross-reaction
The response also turns on the host's own tissue. Damaging it releases new antigens and the response widens, which is known as epitope spreading, so the damage can sustain itself.
Documented in human disease.
Molecular mimicry has been demonstrated in several autoimmune and post-infectious diseases. These are four of the most studied cases, each with its primary source.7
| Disease | Pathogen · molecule | Human target | Type | What was shown | Source |
|---|---|---|---|---|---|
| Rheumatic fever | Streptococcus pyogenesM protein | Cardiac myosin | Protein | Antibodies and T cells from patients cross-react with streptococcal M protein and cardiac myosin, and immunisation with recombinant M protein reproduces valvulitis in a rat model. | [2][6] |
| Guillain–Barré syndrome | Campylobacter jejuniLipo-oligosaccharide | GM1 ganglioside, peripheral nerve | Carbohydrate | Immunisation with the bacterial molecule reproduced the neuropathy in an animal model. | [3] |
| Systemic lupus erythematosus | Epstein–Barr virusEBNA1 | Ro and Sm autoantigens | Protein | The earliest lupus autoantibodies cross-react with EBNA1, and immunisation induced lupus-like autoimmunity in animals. | [4] |
| Multiple sclerosis | Epstein–Barr virusEBNA1 | GlialCAM, central nervous system | Protein | Antibodies from patients' cerebrospinal fluid bind both with high affinity, and EBNA1 immunisation worsened disease in a mouse model. | [5] |
From resemblance to proof.
Between describing a homology and showing it causes disease there are several rungs. Saying which one a finding sits on is what separates a hypothesis from a claim.
Homology described
Two sequences or structures resemble each other above a threshold. At proteome scale chance produces resemblance in abundance, so the immunological question remains wide open.
How we search for it.
A proteome-scale comparison returns thousands of resemblances. Almost all of them are noise. The method is reducing them to the few that deserve an experiment.
- Compare
- Pathogen proteome against the human one, with the thresholds and multiple-comparison corrections that searching at this scale demands.
- Filter
- Anything that cannot be presented or recognised is discarded: resemblance buried inside the structure is of no use to the immune system.
- Contrast
- What survives is checked against the published literature: what is already described, in which disease, and at what level of evidence.
- Validate
- What reaches this point is designed to be tested in the laboratory, with partners.
What we still do not know.
The questions this mechanism leaves open, and the ones we work on.8
Why only a minority
Almost all of us are exposed to the pathogens involved and only a minority fall ill. Which combination of genetics, prior exposure and context makes the difference remains unanswered.
Years between cause and effect
Years can pass between the infection and the diagnosis. Reconstructing that window requires longitudinal data that, until now, no one had gathered.
A resemblance that shifts
Pathogens mutate, and the resemblance moves with them. What happens to risk when a variant brings a molecule closer to the human one is an open question.
Put itto the test.
Research groups, clinicians and pharma R&D teams: if you work on this question, let's talk.
- Oldstone MBA. Molecular mimicry and immune-mediated diseases. FASEB J. 1998;12(13):1255–1265. doi:10.1096/fasebj.12.13.1255
- Cunningham MW. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int Rev Immunol. 2014;33(4):314–329. doi:10.3109/08830185.2014.917411
- Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndrome. Proc Natl Acad Sci U S A. 2004;101(31):11404–11409. doi:10.1073/pnas.0402391101
- McClain MT, Heinlen LD, Dennis GJ, et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005;11(1):85–89. doi:10.1038/nm1167
- Lanz TV, Brewer RC, Ho PP, et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature. 2022;603(7900):321–327. doi:10.1038/s41586-022-04432-7
- Rush CM, Govan BL, Sikder S, Williams NL, Ketheesan N. Animal models to investigate the pathogenesis of rheumatic heart disease. Front Pediatr. 2014;2:116. doi:10.3389/fped.2014.00116
- The selection is illustrative. Each case rests on the cited work, and the level of evidence varies between diseases.
- The open questions describe Neural Omega research hypotheses.